title: Screening for Prostate Cancer: A Review of the ERSPC and PLCO Trials.
abstract: The advent of prostate-specific antigen (PSA) testing in the early 1980s revolutionized the diagnosis of prostate cancer. As a result of PSA testing, there has been a surge in the number of prostate cancer diagnoses. This review examines the results of 2 recent landmark trials that studied the effect of screening on prostate cancer mortality: the European Randomized Study of Screening for Prostate Cancer (ERSPC) and the US-based Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
authors.affiliation: Department of Urology, School of Medicine, New York University New York, NY.
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Eckersberger
authors.forename: Julia
authors.initials: J
authors.lastname: Finkelstein
authors.forename: Helen
authors.initials: H
authors.lastname: Sadri
authors.forename: Markus
authors.initials: M
authors.lastname: Margreiter
authors.forename: Samir S
authors.initials: SS
authors.lastname: Taneja
authors.forename: Herbert
authors.initials: H
authors.lastname: Lepor
authors.forename: Bob
authors.initials: B
authors.lastname: Djavan